Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
AbbVie Biotech Ventures
3135
AbbVie Biotech Ventures
Suggest edits
Follow us
Overview
News
Investments
13
Portfolio
Portfolio Tracker
Add info
Add round
23 Apr
2020
Accent Therapeutics, Inc.
$63,000,000
Venture capital (Series B)
Atlas Venture
,
EcoR1 Capital
,
GV
,
+5
Accent Therapeutics Completes $63M Series B Financing
FinSMEs
+1
10 Aug
2018
Artios Pharma
£65,000,000
Venture capital (Series B)
Novartis Venture Fund
,
Life Sciences Partners
,
IP Group Plc
,
+7
14 Dec
2017
Jnana
$50,000,000
Venture capital (Series A)
Avalon Ventures
,
Polaris Partners
,
Versant Ventures
,
+2
04 Oct
2017
Palleon Pharmaceuticals
$48,000,000
Venture capital (Series A)
SR One
,
AbbVie Biotech Ventures
,
Pfizer Venture Investments
,
+5
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug
Xconomy
27 Sep
2017
AuraSense Therapeutics, LLC
$20,000,000
Venture capital (Series D)
AbbVie Biotech Ventures
,
Eric Lefkofsky
,
Craig Mundie
,
+4
19 Sep
2017
Disarm Therapeutics
$30,000,000
Venture capital (Series A)
Atlas Venture
,
AbbVie Biotech Ventures
,
Lightstone Ventures
25 Jul
2017
Rodeo Therapeutics
$5,900,000
Venture capital (Series A)
ARCH Venture Partners
,
WRF Capital
,
Johnson & Johnson Innovation
,
+6
Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies
businesswire
+1
24 Jul
2017
Effector Therapeutics
$38,600,000
Venture capital (Series C)
SR One
,
Novartis Venture Fund
,
U.S. Venture Partners (USVP)
,
+9
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Xconomy
+1
12 Dec
2016
ApoGen Biotechnologies
$7,000,000
Venture capital (Series A)
Alexandria Venture
,
ARCH Venture Partners
,
WRF Capital
,
+6
ApoGen Biotechnologies Raises $7M in Series A Funding
FinSMEs
+3
30 Jun
2016
Morphic Therapeutic
$51,500,000
Venture capital (Series A)
Polaris Partners
,
SR One
,
Omega Funds
,
+5
23 Apr
2014
Kala Pharmaceuticals
$22,500,000
Venture capital (Series B)
Polaris Partners
,
Lux Capital
,
Third Rock Ventures
,
+3
14 May
2013
Alvine Pharmaceuticals Inc
$70,000,000
Private equity
AbbVie Biotech Ventures
,
AbbVie